Inhibiton Therapeutics Inc. preclinical data

In vitro, ICA-1 inhibited MCF-7 and MDA-MD-468 breast cancer cell lines by 32% and 83%, respectively, vs. controls. Inhibiton Therapeutics previously reported that the protein kinase C-iota inhibitor ...